MRNA vaccine giant Moderna announced on Monday that it will build an mRNA vaccine production plant in Melbourne, Australia, which is the first mRNA vaccine manufacturing and processing center in the southern hemisphere.
The project will be located at Monash University, one of Australia's largest universities. It will produce 100 million doses of vaccines for covid-19, influenza and other diseases every year.
Spike VAX, the mRNA vaccine of Moderna against novel coronavirus, uses the cutting-edge technology of genetically engineered messenger RNA (mRNA). This type of vaccine does not require the steps of virus isolation and cell culture equipment. The construction of mRNA manufacturing facilities will start this year and be completed in 2024. It is reported that 85% of the external buildings of the vaccine factory are glass structures.
Australian Prime Minister Anthony Albanese said: the establishment of the plant is a "demonstration of confidence" of vaccine giant Moderna to Australia. For Australia, after experiencing a severe vaccine shortage during the covid-19 pandemic, the facility is not only about health and science, but also about "national security".
Moderna factory will be located in Melbourne, which will bring more strength and more medical supplies to Australia.
In recent months, the number of covid-19 cases in Australia has surged after restrictions were relaxed. In 2022, novel coronavirus became the third leading cause of death in the country. JieXi company has also made efforts to address this situation, paying attention to the sales of pharmaceutical intermediates related to the treatment of covid-19.
Albanese added: "we have learned a lesson from the pandemic - we need to make more vaccines here, and we cannot always be at the end of the global supply chain."
Welcome to consult and treat the intermediates related to covid-19. JieXi will serve you throughout the process and make joint efforts for the global remission.
